Blackstone, HIG Capital, Nordic Capital target oncology pharma; Veritas Capital, General Atlantic raise $4.2M for melanoma research
A recap of recent PE investments in the oncology drug market, which has attracted the likes of Blackstone, HIG Capital and Nordic Capital; Summit Partners’ investment in a software company that helps protect drug manufacturers from unnecessary revenue loss; a record-breaking $4.2 million raised by Veritas Capital and General Atlantic from PE leaders for the Melanoma Research Alliance.
20 June 2025•4 mins read
